Biotech startup FitBiomics develops probiotics from elite athletes' gut bacteria to boost performance

FitBiomics, a biotech startup, is developing probiotics from gut bacteria found in elite athletes. Their products, V•Nella and Nella, aim to enhance muscle performance and improve sleep, respectively. Users report increased energy and reduced fatigue. The company has raised $6 million and focuses on health rather than disease. Their research identified Veillonella, a bacteria that helps metabolize lactic acid, which can reduce exercise fatigue. This approach contrasts with traditional biotech methods that take longer and cost more. FitBiomics aims to make probiotics accessible and affordable, targeting the growing wellness market. Their innovative model allows for quicker product development and lower costs compared to conventional pharmaceutical approaches.